Abstract, Snapshot, Market Analysis & Market Definition: Basal Cell Carcinoma Treatment Market
Basal cell carcinoma (BCC) is the most common type of skin cancer. It's also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes) may be treated with vismodegib (Erivedge) or sonidegib (Odomzo). The classification of Basal Cell Carcinoma Treatment includes Topical Treatment, Hedgehog Pathway Inhibitor Therapy, Mohs Surgery, Other Surgeries and Other Treatments, and the proportion of Topical Treatment in 2018 is about 30.4%. Basal Cell Carcinoma Treatment is widely used in Hospitals, Specialty Clinics and other field. The most proportion of Basal Cell Carcinoma Treatment is Hospitals, and the sales proportion in 2018 is 53.2%. Market competition is intense. Roche, Sun Pharmaceuticals, Bausch Health Companies, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. In 2018, the global Basal Cell Carcinoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Basal Cell Carcinoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Basal Cell Carcinoma Treatment development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: Basal Cell Carcinoma Treatment Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Topical Treatment
Hedgehog Pathway Inhibitor Therapy
Mohs Surgery
Other Surgeries
Other TreatmentsMohs Surgery accounts for a larger share of the market, about 31% in 2018.
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Hospitals
Specialty Clinics
OthersThe largest application is in hospital, which accounted for 53.15% in 2018.
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: Basal Cell Carcinoma Treatment Market
Roche
Sun Pharmaceuticals
Bausch Health Companies
Taro Pharmaceuticals
Mylan
Key Insights Covered: Exhaustive Basal Cell Carcinoma Treatment Market
1. Market size (sales, revenue and growth rate) of Basal Cell Carcinoma Treatment industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Basal Cell Carcinoma Treatment industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Basal Cell Carcinoma Treatment industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Basal Cell Carcinoma Treatment industry.
Research Methodology: Basal Cell Carcinoma Treatment Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.